POLISCOPE
Back to feed
NewsSan Diego Business JournalAugust 4, 2026San Diego

Erasca, Inc. to release clinical trial data for cancer drug candidates this year

San Diego-based oncology company Erasca, Inc. plans to publish safety and efficacy results for two drug candidates targeting non-small cell lung cancer later this year. The company is currently in the clinical-stage of development for these precision oncology treatments.

biotechnologyoncologyclinical trialsbusiness
Read the full story at San Diego Business Journal

Why It Matters

The release of clinical data will provide information on the safety and effectiveness of new potential treatments for patients.

Key Facts

  • Erasca, Inc. is a clinical-stage precision oncology company.
  • The company is preparing to release safety and efficacy data for two drug candidates.
  • The drug candidates are intended for the treatment of non-small cell lung cancer.
  • The data release is scheduled to occur later this year.
  • The company was founded nearly a decade ago.

Who's Mentioned

otherNasdaq: ERAS“Stock ticker symbol for Erasca, Inc.”organizationErasca, Inc.“A clinical-stage precision oncology company based in San Diego.”locationSan Diego“Headquarters location of Erasca, Inc.”